AKT1 and cancer: Due to the frequency of alterations in the PI3K/AKT/mTOR signaling pathway, its role in promoting cancer cell growth and invasion, and integrative analysis data, targeting of this signaling cascade has a robust rationale with wide-ranging therapeutic implications [134].